NSAID-induced small bowel perforation

ANZ Journal of Surgery

Volumn 71, Issue 4, 2001, Pages 255-256

  Forshaw, M J ^a,c   Zayyan, K ^a   Power, D M ^b  

^a NORFOLK AND NORWICH HOSPITAL   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c Hemingford House   (United Kingdom)

Author keywords

NSAID; Perforation; Review; Small bowel; Small intestine; Ulcer

Indexed keywords

INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ABDOMINAL PAIN; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; HIP FRACTURE; HUMAN; ILEUM DISEASE; INTESTINE PERFORATION; MALE; MIDDLE AGED; PATHOLOGY; POSTOPERATIVE PAIN;

ABDOMINAL PAIN; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; HIP FRACTURES; HUMANS; ILEAL DISEASES; INDOMETHACIN; INTESTINAL PERFORATION; MALE; MIDDLE AGED; PAIN, POSTOPERATIVE;

EID: 0035317158     PISSN: 14451433     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1622.2001.02082.x     Document Type: Article

References (29)

1. Bateman DN. NSAIDs: Time to re-evaluate gut toxicity. Lancet 1994; 343: 1051-2.
2. Joint Formulary Committee. Gastrointestinal system. In: Mehta DK (ed.) British National Formulary 40. London: British Medical Association and the Royal Pharmaceutical Society of Great Britain, 1999.
3. Soll AH. Non steroidal anti-inflammatory drugs and peptic ulcer disease. Ann. Intern. Med. 1991; 114: 307-19.
4. Thompson MR. Indomethacin and perforated duodenal ulcer. BMJ 1980; 280: 448-9.
5. Kent TH, Cardelli RM, Stander FW. Small intestinal ulcers and intestinal flora in rats given indomethacin. Am. J. Pathol. 1969; 54: 237-45.
6. Sturges HF, Krone CL. Ulceration and stricture of the jejunum in a patient on long term indomethacin therapy. Am. J. Gastroenterol. 1973; 53: 162-9.
7. Day TK. Intestinal perforation associated with osmotic slow release indomethacin capsules. BMJ 1983; 287: 1671-2.
8. Schwartz HA. Lower gastrointestinal side effects of non steroidal anti-inflammatory drugs. J. Rheumatol. 1981; 8: 952-4.
9. Coutrot S, Roland D, Barbier J, Van der Marcq P, Alcalay M, Matuchansky C. Acute perforation of colonic diverticula associated with short term indomethacin. Lancet 1978; 2: 1055-6.
10. Langman MJS, Morgan L, Worral A. Use of anti-inflammatory drugs by patients admitted with small or large bowel perforation or haemorrhage. BMJ 1985; 290: 347-9.
11. Allison MC, Allan G, Howatson MB, Torrance MB, Lee FD, Russell RI. Gastrointestinal damage associated with the use of non steroidal anti-inflammatory drugs. N. Engl. J. Med. 1992; 327: 749-54.
12. Morris AJ, Wasson LA, Mackenzie JF. Small bowel enteroscopy in undiagnosed gastrointestinal blood loss. Gut 1992; 33: 887-9.
13. Morris AJ, Madhok R, Sturrock RD et al. Enteroscopic diagnosis of small bowel ulceration in patients receiving non steroidal anti-inflammatory drugs. Lancet 1991; 337: 520.
14. Grosfeld JL, Chaet M, Molinari F et al. Increased risk of necrotising enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin. Ann. Surg. 1996; 224: 350-7.
15. Fejgin MD, Delpino ML, Bidiwala KS. Isolated small bowel perforation following intrauterine treatment with indomethacin. Am. J. Perinatol. 1994; 11: 295-6.
16. Kessler WF, Shires GT, Fahey TJ. Surgical complications of nonsteroidal anti-inflammatory drug-induced small bowel ulceration. J. Am. Coll. Surg. 1997; 185: 250-4.
17. Davies DR, Brightmore T. Idiopathic and drug-induced ulceration of the small intestine. Br. J. Surg. 1970; 57: 134-9.
18. Bjarnson I, Hayllar J, Macpherson A, Russell AS. Side effects of non steroidal anti-inflammatory drugs on the small and large intestines in humans. Gastroenterology 1993; 104: 1832-47.
19. Deakin M. Small bowel perforation associated with an excessive dose of slow release diclofenac sodium. BMJ 1988; 297: 488-9.
20. Robert A. An intestinal disease produced experimentally by a prostaglandin deficiency. Gastroenterology 1975; 69: 1045-7.
21. Tokumitsu Y, Lee S, Ui M. In vitro effects of non steroidal anti-inflammatory drugs on oxidative phosphorylation in rat mitochondria. Biochem. Pharmacol. 1977; 26: 2101-9.
22. Banerjee AK, Marway JS, Preedy VR, Peters TJ. Studies of gut mucosal protein synthesis in a non steroidal anti-inflammatory drug (NSAID) model of inflammatory bowel disease. Gut 1992; 33: 242-5.
23. Wax J, Cliger WA, Varner P, Bass P, Winder W. Relationship of the enterohepatic cycle to ulcerogenesis in the rat small bowel with flufenamic acid. Gastroenterology 1970; 58: 772-80.
24. Bjarnson I. Clinicopathological features of non steroidal anti-inflammatory drug-induced small intestinal strictures. Gastroenterology 1988; 94: 1070-4.
25. Boydstun JS Jr, Gaffey TA, Bartholomew LG. Clinicopathologic study of non-specific ulcers of the small intestine. Dig. Dis. Sci. 1981; 26: 911-16.
26. Aabakken L, Larsen S, Osnes M. Cimetidine tablets or suspension for the prevention of gastrointestinal mucosal lesions caused by non steroidal anti-inflammatory drugs. Scand. J. Rheumatol. 1989; 18: 369-75.
27. Aabakken L, Larsen S, Osnes M. Sucralfate for prevention of naproxen-induced mucosal lesions in the proximal and distal gastrointestinal tract. Scand. J. Rheumatol. 1989; 18: 361-8.
28. Waisman Y, Zahavi I, Marcus H et al. Sucralfate is protective against intestinal induced ulceration in the rat. Digestion 1988; 41: 78-82.
29. Morris AJ, Murray L, Sturrock RD, Madhok R, Capell HA, Mackenzie JF. Short report: The effect of misoprostol on the anaemia of NSAID enteropathy. Aliment. Pharmacol. Ther. 1994; 8: 343-6.